These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2459090

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
    Ohsaka A, Kitagawa S, Yuo A, Motoyoshi K, Furusawa S, Miura Y, Takaku F, Saito M.
    Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia.
    Yuo A, Kitagawa S, Okabe T, Urabe A, Komatsu Y, Itoh S, Takaku F.
    Blood; 1987 Aug; 70(2):404-11. PubMed ID: 3038212
    [Abstract] [Full Text] [Related]

  • 4. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
    Nagler A, Ginzton N, Negrin R, Bang D, Donlon T, Greenberg P.
    Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
    [Abstract] [Full Text] [Related]

  • 5. Hematologic and cytogenetic findings in myelodysplastic syndromes treated with recombinant human granulocyte colony-stimulating factor.
    Ohyashiki K, Ohyashiki JH, Toyama K, Takaku F.
    Jpn J Cancer Res; 1989 Sep; 80(9):848-54. PubMed ID: 2480943
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
    Negrin RS, Haeuber DH, Nagler A, Olds LC, Donlon T, Souza LM, Greenberg PL.
    Ann Intern Med; 1989 Jun 15; 110(12):976-84. PubMed ID: 2471429
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor.
    Greenberg P, Negrin R, Nagler A, Vincent M, Donlon T.
    Int J Cell Cloning; 1990 Jan 15; 8 Suppl 1():293-300; discussion 300-2. PubMed ID: 1691248
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Kinetics and mechanisms of recombinant human granulocyte-colony stimulating factor-induced neutrophilia.
    Ulich TR, del Castillo J, Souza L.
    Am J Pathol; 1988 Dec 15; 133(3):630-8. PubMed ID: 2462357
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.